Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2APAB | ISIN: SE0008348262 | Ticker-Symbol: 5JD
Frankfurt
28.03.24
09:16 Uhr
0,185 Euro
-0,003
-1,60 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
EXPRES2ION BIOTECH HOLDING AB Chart 1 Jahr
5-Tage-Chart
EXPRES2ION BIOTECH HOLDING AB 5-Tage-Chart

Aktuelle News zur EXPRES2ION BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
29.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion to present in investor and R&D events in March1
21.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion's Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic's Clinical Phase III Study for the COVID-19 Vaccine9
08.02.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces financial results for the fourth quarter and full-year 20231
22.01.EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion to present in Redeye Fight Cancer event and the Bio Innovation Leaders Summit1
12.12.23EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion to present new Nipah virus vaccine project in upcoming webcast1
04.12.23EXPRES2ION BIOTECHNOLOGIES: Pareto Securities publishes research report2
01.12.23EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces new EU-funded Horizon Europe grant award for Nipah virus vaccine development1
27.11.23EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report1
16.11.23EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion announces financial results for the third quarter 20231
09.11.23ExpreS2ion Biotechnologies: Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB held on 9 November 20232
03.11.23EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion to participate in upcoming events1
25.10.23EXPRES2ION BIOTECHNOLOGIES: Background and rationale for the proposed incentive program 2023/20262
23.10.23EXPRES2ION BIOTECHNOLOGIES: Notice of Extraordinary General Meeting in ExpreS2ion Biotech Holding AB2
12.10.23EXPRES2ION BIOTECHNOLOGIES: ExpreS2ion to participate in upcoming events2
05.05.23Nasdaq Stockholm AB: New equity right for trading, ExpreS2ion Biotech Holding AB TO8 (249/23)262At the request of ExpreS2ion Biotech Holding AB, equity rights will be traded on First North Growth Market as from May 8, 2023. Security name: ExpreS2ion Biotech Holding AB TO8 ------------------------------------------------- Short...
► Artikel lesen
28.04.23Nasdaq Stockholm AB: Last day of trading in paid subscription units (BTU) of ExpreS2ion Biotech Holding AB (238/23)344Trading in ExpreS2ion Biotech Holding AB paid subscription units is to cease. The last trading day is May 2, 2023. Short name: EXPRS2 BTU --------------------------- ISIN code: SE0019925017 --------------------------- Orderbook...
► Artikel lesen
16 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1